ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626108 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626108; 2) Community: the network communities that were significantly associated with the response to NSC 626108; 3) Molecule: the relationships between components within communities and NSC 626108; 4) MDR: the compounds that were significantly associated with the NSC 626108.

NSC Compound Enrichment Correlation
NSC 329250 Null 0.0422011701988039 -0.067705102
NSC 606985 Camptothecin Derivative 0.0422011701988039 -0.12843112
NSC 638623 Null 0.0422011701988039 0.080409387
NSC 645566 Null 0.0422011701988039 0.20773689
NSC 647117 Null 0.0422011701988039 -0.047578479
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.0422011701988039 0.13751139
NSC 667904 1-(8-(2,3-dimethoxyphenyl)-7-methyl-7,8-dihydro-6H-[1,3]dioxolo[4,5-g]chromen-6-yl)-2-phenylhydrazine 0.0422011701988039 0.20482724
NSC 672215 Null 0.0422011701988039 0.15317938
NSC 678925 1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride 0.0422011701988039 0.0042777055
NSC 682011 Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- 0.0422011701988039 0.28416372
Total:53  Current:38    [First] [Prev] [Next] [Last]